HF Advisory Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $359K | Sell |
9,354
-401
| -4% | -$15.4K | 0.14% | 134 |
|
|
2025
Q1 | $378K | Buy |
9,755
+1,012
| +12% | +$39.2K | 0.17% | 130 |
|
|
2024
Q4 | $296K | Buy |
8,743
+990
| +13% | +$33.5K | 0.14% | 136 |
|
|
2024
Q3 | $317K | Sell |
7,753
-717
| -8% | -$29.3K | 0.15% | 135 |
|
|
2024
Q2 | $326K | Buy |
8,470
+405
| +5% | +$15.6K | 0.17% | 134 |
|
|
2024
Q1 | $346K | Sell |
8,065
-462
| -5% | -$19.8K | 0.19% | 131 |
|
|
2023
Q4 | $316K | Sell |
8,527
-179
| -2% | -$6.63K | 0.2% | 131 |
|
|
2023
Q3 | $315K | Buy |
8,706
+201
| +2% | +$7.27K | 0.23% | 122 |
|
|
2023
Q2 | $303K | Buy |
8,505
+369
| +5% | +$13.2K | 0.24% | 114 |
|
|
2023
Q1 | $289K | Buy |
8,136
+674
| +9% | +$24K | 0.26% | 113 |
|
|
2022
Q4 | $262K | Buy |
+7,462
| New | +$262K | 0.27% | 114 |
|